FIELD: medicine.
SUBSTANCE: invention refers to indolocarbazole derivatives blocking tumour vasculogenic mimicry and applicable in medicine, of general formula I: , wherein Gly is pentose and hexose residues, R represents an amino group of 6-amino-12-(α-L-arabinopyranosyl)indolo[2,3-a]pyrrolo[3,4-c]carbazole-5,7-dione; a formamido group of 6-formamido-12-(β-D-xylopyranosyl)indolo[2,3-a]pyrrolo[3,4-c]carbazole-5,7-dione; an oxylethylamino group of 6-(2-oxyethyl)amino-12-(α-L-arabinopyranosyl)indolo[2,3-a]pyrrolo[3,4-c]carbazole-5,7-dione; a cyanoethylamino group of 6-(2-cyanoethyl)amino-12-(β-D-xylopyranosyl)indolo[2,3-a]pyrrolo[3,4-c]carbazole-5,7-dione and 6-(2-cyanoethyl)amino-12-(β-D-galactopyranosyl)indolo[2,3-a]pyrrolo[3,4-c]carbazole-5,7-dione; a picolinamido group of 6-picolinamido-12-(β-D-xylopyranosyl)indolo[2,3-a]pyrrolo[3,4-c]carbazole-5,7-dione.
EFFECT: there are presented new compounds with the cytotoxic and antiangiogenic properties active with respect to HCT-116 colon cancer and Mel Kor melanoma.
6 ex, 1 tbl, 3 dwg
Title | Year | Author | Number |
---|---|---|---|
N-GLYCOSIDES OF INDOLO[2,3-a]PYRROLO[3,4-c]CARBAZOLES HAVING ANTITUMOUR ACTIVITY | 2014 |
|
RU2548045C1 |
DERIVATIVE OF THE CLASS OF N-GLYCOSIDES INDOLO[2,3-A]PYRROLO[3,4-C]CARBAZOLE-5,7-DIONE - N-{12-(β-D-XYLOPYRANOSYL)-5,7-DIOXO-INDOLO[2,3-A]PYRROLO[3,4-C]CARBAZOL-6-YL} PYRIDINE-2-CARBOXAMIDE, WHICH HAS CYTOTOXIC AND ANTITUMOR ACTIVITY | 2017 |
|
RU2667906C1 |
ANTITUMOUR AGENT | 2014 |
|
RU2572691C1 |
METHOD OF PRODUCING INDOLO[2,3]PYRROLO[3,4-c]CARBAZOLE-5,7-DIONES N-GLYCOSIDES EXHIBITING CYTOTOXIC AND ANTICANCER ACTIVITY | 2009 |
|
RU2427585C9 |
TUMOUR THERAPY AGENT | 2019 |
|
RU2726801C1 |
DERIVATIVES OF GLYCOSIDES OF INDOLO[2,3-A]-PYRROLO[3,4-C]CARBAZOL-5,7-DIONES ELICITING CYTOTOXIC AND ANTITUMOR ACTIVITY | 2003 |
|
RU2255089C1 |
ANTI-CANCER DRUG TOPOISOMERASE I INHIBITOR | 2022 |
|
RU2786727C1 |
METHOD FOR TREATMENT OF SW620 HUMAN COLON CANCER IN EXPERIMENT | 2017 |
|
RU2665168C1 |
METHOD FOR PRODUCING AMINO ACID ANALOGUES OF THE ANTITUMOUR ANTIBIOTIC REBECCAMYCIN | 2020 |
|
RU2755572C1 |
INDOLOPYRROLOCARBAZOLE DERIVATIVES OF SUGARS, PHARMACEUTICAL COMPOSITION CONTAINING THEREOF AND METHOD OF INHIBITION OF TUMOR PROLIFERATION | 1997 |
|
RU2167880C2 |
Authors
Dates
2015-07-27—Published
2014-09-09—Filed